Both the cure rate and morbidity of upper urinary tract urothelial carcinoma are sensitive to nuances of treatment so appropriate management is crucial. Here, Chromecki et al. discuss a number of potential prognostic factors—encompassing clinical characteristics, pathological factors and molecular markers—that might be utilized clinically to identify patients in need of more-aggressive therapy.
- Thomas F. Chromecki
- Karim Bensalah
- Shahrokh F. Shariat
